Cargando…

Identification of a Novel NRG1 Fusion with Targeted Therapeutic Implications in Locally Advanced Pediatric Cholangiocarcinoma: A Case Report

Locally advanced cholangiocarcinoma has a poor prognosis, with long-term survival only for patients where complete surgical resection is achieved. Median overall survival with chemotherapy alone is less than 1 year. Novel strategies combining conventional chemotherapy and radiotherapy followed by ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Sarah G., Basu, Gargi D., Eaton, Bree, Goodman, Laurie J., Goldsmith, Kelly C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119779/ https://www.ncbi.nlm.nih.gov/pubmed/37092120 http://dx.doi.org/10.1159/000530164

Ejemplares similares

NRG1 fusions in breast cancer
por: Howarth, Karen D., et al.
Publicado: (2021)

Identification of Novel CDH1-NRG2α and F11R-NRG2α Fusions in NSCLC Plus Additional Novel NRG2α Fusions in Other Solid Tumors by Whole Transcriptome Sequencing
por: Ou, Sai-Hong Ignatius, et al.
Publicado: (2020)

Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung
por: Shin, Dong Hoon, et al.
Publicado: (2016)

NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma
por: Duruisseaux, Michaël, et al.
Publicado: (2016)

Clinicopathological Characteristics of NRG1 Fusion–Positive Solid Tumors in Korean Patients
por: Cha, Yoon Jin, et al.
Publicado: (2023)

CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization
por: Werr, Lisa, et al.
Publicado: (2022)

Pemigatinib for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions/rearrangements
por: Walden, Daniel, et al.
Publicado: (2022)

Infigratinib for the Treatment of Metastatic or Locally Advanced Cholangiocarcinoma With Known FGFR2 Gene Fusions or Rearrangements
por: White, Kathryn, et al.
Publicado: (2023)

Durable response to afatinib in advanced lung adenocarcinoma harboring a novel NPTN-NRG1 fusion: a case report
por: Nie, Xin, et al.
Publicado: (2023)

Effects of RET, NRG1 and NRG3 Polymorphisms in a Chinese Population with Hirschsprung Disease
por: Yang, Dehua, et al.
Publicado: (2017)

Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
por: Churi, Chaitanya R., et al.
Publicado: (2014)

NRG-1 talks back to neurons
por: LeBrasseur, Nicole
Publicado: (2003)

Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications
por: Wu, Hsing-Ju, et al.
Publicado: (2019)

Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma
por: Moureau-Zabotto, Laurence, et al.
Publicado: (2013)

Management of Locally Advanced or Metastatic Combined Hepatocellular Cholangiocarcinoma
por: Zhao, Jemmy, et al.
Publicado: (2023)

Back signaling by the Nrg-1 intracellular domain
por: Bao, Jianxin, et al.
Publicado: (2003)

Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression
por: Trombetta, Domenico, et al.
Publicado: (2018)

Successful targeting of the NRG1 fusion reveals durable response to afatinib in lung adenocarcinoma: a case report
por: Wu, Xiaokang, et al.
Publicado: (2021)

Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
por: Neumann, Olaf, et al.
Publicado: (2022)

New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma
por: Massironi, Sara, et al.
Publicado: (2020)

Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice
por: Spencer, Jarrah R., et al.
Publicado: (2013)

Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma
por: Lee, Sang-Jae, et al.
Publicado: (2014)

Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
por: Jung, Jang Han, et al.
Publicado: (2017)

Fine Mapping of the NRG1 Hirschsprung's Disease Locus
por: Tang, Clara Sze-Man, et al.
Publicado: (2011)

NRG1 variant effects in patients with Hirschsprung disease
por: Gunadi, et al.
Publicado: (2018)

Nrg1 Intracellular Signaling Is Neuroprotective upon Stroke
por: Navarro-González, Carmen, et al.
Publicado: (2019)

Cancer Stem Cells in Intrahepatic Cholangiocarcinoma; Their Molecular Basis, and Therapeutic Implications
por: Tamai, Keiichi, et al.
Publicado: (2022)

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study
por: Seamon, Leigh G, et al.
Publicado: (2018)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma
por: Sandler, Kiri A., et al.
Publicado: (2016)

Photochemical Internalization of Gemcitabine Is Safe and Effective in Locally Advanced Inoperable Cholangiocarcinoma
por: Trojan, Jörg, et al.
Publicado: (2022)

Expression of NRG1 and its receptors in human bladder cancer
por: Forster, J A, et al.
Publicado: (2011)

Cell Surface Expression of Nrg1 Protein in Candida auris
por: Paudyal, Anuja, et al.
Publicado: (2021)

The impact of NRG1 expressions and methylation on multifactorial Hirschsprung disease
por: Gunadi, et al.
Publicado: (2022)

Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study
por: Shi, Guo‐Ming, et al.
Publicado: (2022)

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials
por: Hallemeier, Christopher L., et al.
Publicado: (2023)

Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology
por: Gensheimer, Michael F., et al.
Publicado: (2020)

Advances in the management of cholangiocarcinoma
por: Zori, Andreas G, et al.
Publicado: (2021)

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
por: Mazzaferro, Vincenzo, et al.
Publicado: (2018)

The role and implication of autophagy in cholangiocarcinoma
por: Khizar, Hayat, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lbq32qr3c5in2oa8r0dd7fsdje